BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20018626)

  • 21. Phospholipase D activation by platelet-activating factor, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils. Phospholipase D activation is involved in enzyme release.
    Kanaho Y; Kanoh H; Saitoh K; Nozawa Y
    J Immunol; 1991 May; 146(10):3536-41. PubMed ID: 1851192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of phospholipase D activation by CYL-26z in formyl peptide-stimulated neutrophils involves the blockade of RhoA activation.
    Kuan YH; Lin RH; Tsao LT; Chen YL; Tzeng CC; Wang JP
    Biochem Pharmacol; 2005 Sep; 70(6):901-10. PubMed ID: 16024001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF).
    Johnson MS; Robertson DN; Holland PJ; Lutz EM; Mitchell R
    Cell Signal; 2006 Oct; 18(10):1793-800. PubMed ID: 16545942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocytic NADPH oxidase links ARNO-Arf6 signaling pathway in glucose-stimulated insulin secretion from the pancreatic β-cell.
    Jayaram B; Kowluru A
    Cell Physiol Biochem; 2012; 30(6):1351-62. PubMed ID: 23095975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
    Schmid E; Figala V; Ullrich V
    Mol Pharmacol; 1994 May; 45(5):815-25. PubMed ID: 8190099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staurosporine and its derivatives enhance f-Met-Leu-Phe-induced superoxide production via phospholipase D activation in human polymorphonuclear leukocytes.
    Mori T; Ando M; Takagi K
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):422-8. PubMed ID: 7981927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18.
    Carrigan SO; Pink DB; Stadnyk AW
    J Leukoc Biol; 2007 Dec; 82(6):1575-84. PubMed ID: 17724165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of formyl peptide-stimulated phospholipase D activation by Fal-002-2 via blockade of the Arf6, RhoA and protein kinase C signaling pathways in rat neutrophils.
    Tsai YR; Huang LJ; Lin HY; Hung YJ; Lee MR; Kuo SC; Hsu MF; Wang JP
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):507-19. PubMed ID: 23525454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of NADPH oxidase by docosahexaenoic acid hydroperoxide and its inhibition by a novel retinal pigment epithelial protein.
    Wu GS; Rao NA
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):831-9. PubMed ID: 10102279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transduction mechanisms of C1q-mediated superoxide production. Evidence for the involvement of temporally distinct staurosporine-insensitive and sensitive pathways.
    Goodman EB; Tenner AJ
    J Immunol; 1992 Jun; 148(12):3920-8. PubMed ID: 1318335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADP-ribosylation factor and Rho proteins mediate fMLP-dependent activation of phospholipase D in human neutrophils.
    Fensome A; Whatmore J; Morgan C; Jones D; Cockcroft S
    J Biol Chem; 1998 May; 273(21):13157-64. PubMed ID: 9582356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of vicinal dithiols in differential regulation of fMLP and phorbol ester-activated phospholipase D in stimulated human neutrophils.
    Planat V; Tronchere H; Record M; Ribbes G; Chap H
    Biochem Biophys Res Commun; 1996 Jan; 218(3):847-53. PubMed ID: 8579603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptors signal through EFA6A-ARF6 to activate phospholipase D in clonal beta-cells.
    Grodnitzky JA; Syed N; Kimber MJ; Day TA; Donaldson JG; Hsu WH
    J Biol Chem; 2007 May; 282(18):13410-8. PubMed ID: 17353194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytohesin 2/ARF6 regulates preadipocyte migration through the activation of ERK1/2.
    Davies JC; Tamaddon-Jahromi S; Jannoo R; Kanamarlapudi V
    Biochem Pharmacol; 2014 Dec; 92(4):651-60. PubMed ID: 25450674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTP gamma S-stimulated polymorphonuclear leukocytes.
    Mansfield PJ; Carey SS; Hinkovska-Galcheva V; Shayman JA; Boxer LA
    Blood; 2004 Mar; 103(6):2363-8. PubMed ID: 14615385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable.
    Sato T; Hongu T; Sakamoto M; Funakoshi Y; Kanaho Y
    Mol Cell Biol; 2013 Jan; 33(1):136-45. PubMed ID: 23109426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipase D mediates Fc gamma receptor activation of neutrophils and provides specificity between high-valency immune complexes and fMLP signaling pathways.
    Gewirtz AT; Simons ER
    J Leukoc Biol; 1997 Apr; 61(4):522-8. PubMed ID: 9103240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a plasma membrane-associated guanine nucleotide exchange factor for ARF6 in chromaffin cells. Possible role in the regulated exocytotic pathway.
    Caumont AS; Vitale N; Gensse M; Galas MC; Casanova JE; Bader MF
    J Biol Chem; 2000 May; 275(21):15637-44. PubMed ID: 10748097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.
    Herlemann A; Keller P; Schott M; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Yu Q; Waidelich R; Strittmatter F; Stief CG; Gratzke C; Hennenberg M
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F47-F57. PubMed ID: 28855187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.